Acute Liver Failure From Amiodarone Infusion: A Survivor's Tale: 2324
… We aim to report the only case of amiodarone-induced ALF in the existing English … liver
disease was admitted with atrial flutter. She was being treated with intravenous (IV) amiodarone …
disease was admitted with atrial flutter. She was being treated with intravenous (IV) amiodarone …
Drug reactive metabolite-induced hepatotoxicity: A Comprehensive review
P Mahajan, M Palkar, RB Pingili - Toxicology Mechanisms and …, 2024 - Taylor & Francis
… Clinically evident liver disease develops in up to 1% of patients treated with amiodarone each
… The cause of amiodarone-related liver damage seems to be direct harm to the layers of fat …
… The cause of amiodarone-related liver damage seems to be direct harm to the layers of fat …
diagnosis, pathophysiology and management of atrial fibrillation in cirrhosis and portal hypertension
B Vandenberk, MH Altieri, H Liu… - Alimentary …, 2023 - Wiley Online Library
… in cirrhosis, sotalol is relatively contraindicated. While amiodarone is well known for causing
QT prolongation, the risk of ventricular arrythmias is significantly lower with amiodarone as it …
QT prolongation, the risk of ventricular arrythmias is significantly lower with amiodarone as it …
Two sides of the coin: Amiodarone-induced lung toxicity-Case Report.
K Garbacki, K Jóźwik, K Kleczaj… - Journal of Pre …, 2022 - search.ebscohost.com
… , amiodarone is a lipophilic drug which can accumulate in the liver causing amiodaroneinduced
liver disease… Amiodarone causes liver damage, ranging from asymptomatic increases in …
liver disease… Amiodarone causes liver damage, ranging from asymptomatic increases in …
S2757 Not All Ascites Is From Cirrhosis
… Amiodarone caused … amiodarone can cause DILI and the history of hepatitis B infection
complicated this case. Quick identification of BRASH allowed for discontinuation of amiodarone, …
complicated this case. Quick identification of BRASH allowed for discontinuation of amiodarone, …
Amiodarone: A Cryptic Culprit For Cirrhosis Associated Respiratory Failure
O Awan, M Mahmoudi, A Basavaraj… - A48. CONVENTIONAL …, 2016 - atsjournals.org
… Liver failure is a rare manifestation of amiodarone toxicity and an uncommon cause of …
We report a case of amiodarone-induced hepatotoxicity manifesting as respiratory failure in …
We report a case of amiodarone-induced hepatotoxicity manifesting as respiratory failure in …
[HTML][HTML] Life-Threatening Electrical Storm Following Liver Transplantation: A Case Report
DRA Coelho, RO da Luz, ST Basto… - The American Journal …, 2024 - ncbi.nlm.nih.gov
… We hypothesize that cirrhotic cardiomyopathy could be the cause of her recurrent … Upon
consulting the electrophysiology team, it was recommended to discontinue using amiodarone …
consulting the electrophysiology team, it was recommended to discontinue using amiodarone …
S2753 A Brash Case of Liver Injury
O Alipour - Official journal of the American College of …, 2021 - journals.lww.com
… cirrhosis due to hepatitis B on tenofovir, atrial fibrillation on apixaban, who recently initiated
amiodarone… The frequency with which amiodarone can cause DILI and the history of hepatitis …
amiodarone… The frequency with which amiodarone can cause DILI and the history of hepatitis …
[HTML][HTML] Non-alcoholic fatty liver disease (NAFLD) and risk of hospitalization for Covid-19.
CT Bramante, CJ Tignanelli, N Dutta, E Jones… - MedRxiv, 2020 - ncbi.nlm.nih.gov
… Findings of protective effects from amiodarone and alcohol use may indicate 1) anticoagulant
use given for the arrhythmia the amiodarone is used for, and 2) coagulopathy caused by …
use given for the arrhythmia the amiodarone is used for, and 2) coagulopathy caused by …
… supplementation on insulin resistance, lipids, inflammatory factors and nesfatin among obese patients with non-alcoholic fatty liver disease (NAFLD): a trial protocol
SA Jazayeri-Tehrani, SM Rezayat, S Mansouri… - BMJ open, 2017 - bmjopen.bmj.com
… Due to the lack of studies regarding curcumin effects on obese patients with non-alcoholic
fatty liver disease (NAFLD), our protocol was designed to assess nanocurcumin impacts on …
fatty liver disease (NAFLD), our protocol was designed to assess nanocurcumin impacts on …